Vivos Inc. (OTCMKTS:RDGL – Get Free Report)’s stock price was down 2.2% on Friday . The company traded as low as $0.11 and last traded at $0.12. Approximately 971,878 shares traded hands during trading, a decline of 22% from the average daily volume of 1,244,290 shares. The stock had previously closed at $0.12.
Vivos Trading Down 2.2 %
The stock’s 50 day moving average price is $0.15 and its 200 day moving average price is $0.16. The firm has a market cap of $51.13 million, a PE ratio of -12.17 and a beta of 1.03.
Vivos Company Profile
Vivos Inc, a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals.
Recommended Stories
- Five stocks we like better than Vivos
- What Are Growth Stocks and Investing in Them
- Energy Vault Soars 100%: CEO Shares Why in MarketBeat Exclusive
- Consumer Discretionary Stocks Explained
- Meta’s Q3 Earnings Beat—Is This Dip a Golden Entry Opportunity?
- Why Are These Companies Considered Blue Chips?
- Top Nuclear Stocks Thriving on Soaring Energy Demand
Receive News & Ratings for Vivos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vivos and related companies with MarketBeat.com's FREE daily email newsletter.
